STEIK JASON PAUL (Chief Clinical Officer) sold 8.4% of their position (1.39K shares) of PENNANT GROUP, INC. on the open market
Open‑market sale worth $53.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/10/2026ACC: 0002078374-26-000003
Officer· Chief Clinical Officer
Since Mar 2026
-1.39K
Net shares
Net seller
$53.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.39K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.39K
Price / share
$38.52
Trade value
$53.70K
% of position
8.4%
8/6/2026
16.50K→15.11K
Total
Net shares
−1.39K
Net value
-$53.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/6/2026 | S · Sale | −1.39K | $38.52 | $53.70K | 8.4% | 16.50K | 15.11K |
| Total | −1.39K | -$53.70K | ||||||
Derivative Transactions0
No derivative transactions reported